Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues

Journal of Experimental and Clinical Cancer Research

Volumn 31, Issue 1, 2012, Pages

  Guan, Peng ^a,b   Yin, Zhihua ^a,b   Li, Xuelian ^a,b   Wu, Wei ^a,b   Zhou, Baosen ^a,b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Key Laboratory of Cancer Etiology and Prevention (China Medical University)   (China)

Author keywords

Lung cancer; Meta analysis; MicroRNAs; Profiling

Indexed keywords

MICRORNA; MICRORNA 125A; MICRORNA 126; MICRORNA 130A; MICRORNA 138; MICRORNA 139; MICRORNA 140; MICRORNA 143; MICRORNA 144; MICRORNA 145; MICRORNA 16; MICRORNA 182; MICRORNA 18B; MICRORNA 195; MICRORNA 198; MICRORNA 20A; MICRORNA 21; MICRORNA 210; MICRORNA 218; MICRORNA 30A; MICRORNA 30B; MICRORNA 30C; MICRORNA 30D; MICRORNA 31; MICRORNA 32; MICRORNA 451; MICRORNA 486; MICRORNA 497; MICRORNA 96; MICRORNA 99A; UNCLASSIFIED DRUG;

CANCER TISSUE; DOWN REGULATION; GENE EXPRESSION PROFILING; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; UPREGULATION;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84861798830     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-31-54     Document Type: Review

References (45)

1. Global cancer statistics. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, CA Cancer J Clin 2011 61 69 90 10.3322/caac.20107 21296855
2. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, Int J Cancer 2010 127 2893 2917 10.1002/ijc.25516 21351269
3. Non-small-cell lung cancer. Goldstraw P, Ball D, Jett JR, Le Chevalier T, Lim E, Nicholson AG, Shepherd FA, Lancet 2011 378 1727 1740 10.1016/S0140-6736(10)62101-0 21565398
4. Small-cell lung cancer. van Meerbeeck JP, Fennell DA, De Ruysscher DK, Lancet 2011 378 1741 1755 10.1016/S0140-6736(11)60165-7 21565397
5. Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study. OByrne KJ, Gatzemeier U, Bondarenko I, Barrios C, Eschbach C, Martens UM, Hotko Y, Kortsik C, Paz-Ares L, Pereira JR, von Pawel J, Ramlau R, Roh JK, Yu CT, Stroh C, Celik I, Schueler A, Pirker R, Lancet Oncol 2011 12 795 805 10.1016/S1470-2045(11)70189-9 21782507
6. Personalized medicine in lung cancer: what we need to know. Mok TS, Nat Rev Clin Oncol 2011 8 661 668 10.1038/nrclinonc.2011.126 21862980
7. Gene expression-based prognostic signatures in lung cancer: ready for clinical use? Subramanian J, Simon R, J Natl Cancer Inst 2010 102 464 474 10.1093/jnci/djq025 20233996
8. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M, Dumitru CD, Shimizu M, Zupo S, Dono M, Alder H, Bullrich F, Negrini M, Croce CM, Proc Natl Acad Sci USA 2004 101 9740 9744 10.1073/pnas.0403293101 15210942
9. A microRNA expression signature of human solid tumors defines cancer gene targets. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM, Proc Natl Acad Sci USA 2006 103 2257 2261 10.1073/pnas.0510565103 16461460
10. Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies. Hui A, How C, Ito E, Liu FF, BMC Cancer 2011 11 500 10.1186/1471-2407-11-500 22128797
11. Role of microRNAs in plant and animal development. Carrington JC, Ambros V, Science 2003 301 336 338 10.1126/science.1085242 12869753
12. MicroRNAs as novel regulators of angiogenesis. Suárez Y, Sessa WC, Circ Res 2009 104 442 454 10.1161/CIRCRESAHA.108.191270 19246688
13. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, van Rooij E, Olson EN, Cancer Cell 2010 18 282 293 10.1016/j.ccr.2010.08.013 20832755
14. Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non-Small Cell Lung Cancers. Heller G, Weinzierl M, Noll C, Babinsky V, Ziegler B, Altenberger C, Minichsdorfer C, Lang G, Döme B, End-Pfützenreuter A, Arns BM, Grin Y, Klepetko W, Zielinski CC, Zöchbauer-Müller S, Clin Cancer Res 2012 18 1619 1629 10.1158/1078-0432.CCR-11-2450 22282464
15. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ, J Thorac Oncol 2011 6 482 488 10.1097/JTO.0b013e318208c785 21258252
16. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM, Proc Natl Acad Sci USA 2004 101 9309 9314 10.1073/pnas.0401994101 15184677
17. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. Griffith OL, Melck A, Jones SJ, Wiseman SM, J Clin Oncol 2006 24 5043 5051 10.1200/JCO.2006.06.7330 17075124
18. Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Chan SK, Griffith OL, Tai IT, Jones SJ, Cancer Epidemiol Biomarkers Prev 2008 17 543 552 10.1158/1055-9965.EPI-07-2615 18349271
19. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, Calabrò E, Croce CM, Pastorino U, Sozzi G, Proc Natl Acad Sci USA 2011 108 3713 3718 10.1073/pnas.1100048108 21300873
20. miRNA expression profiling of lung adenocarcinomas: correlation with mutational status. Dacic S, Kelly L, Shuai Y, Nikiforova MN, Mod Pathol 2010 23 1577 1582 10.1038/modpathol.2010.152 20818338
21. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y, Biomed Pharmacother 2010 64 399 408 10.1016/j.biopha.2010.01.018 20363096
22. Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers. Jang J, Jeon HS, Sun Z, Aubry MC, Tang H, Park CH, Rakhshan F, Schultz DA, Kolbert CP, Lupu R, Park JY, Harris CC, Yang P, Jin J, Clin Cancer Res 2012 in press 23136197
23. An integrated analysis of miRNA and mRNA expressions in non-small cell lung cancers. Ma L, Huang Y, Zhu W, Zhou S, Zhou J, Zeng F, Liu X, Zhang Y, Yu J, PLoS One 2011 6 26502 10.1371/journal.pone.0026502 22046296
24. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG, Cancer Res 2009 69 5776 5783 10.1158/0008-5472.CAN-09-0587 19584273
25. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Seike M, Goto A, Okano T, Bowman ED, Schetter AJ, Horikawa I, Mathe EA, Jen J, Yang P, Sugimura H, Gemma A, Kudoh S, Croce CM, Harris CC, Proc Natl Acad Sci USA 2009 106 12085 12090 10.1073/pnas.0905234106 19597153
26. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis. Tan X, Qin W, Zhang L, Hang J, Li B, Zhang C, Wan J, Zhou F, Shao K, Sun Y, Wu J, Zhang X, Qiu B, Li N, Shi S, Feng X, Zhao S, Wang Z, Zhao X, Chen Z, Mitchelson K, Cheng J, Guo Y, He J, Clin Cancer Res 2011 17 6802 6811 10.1158/1078-0432.CCR-11-0419 21890451
27. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer. Võsa U, Vooder T, Kolde R, Fischer K, Välk K, Tõnisson N, Roosipuu R, Vilo J, Metspalu A, Annilo T, Genes Chromosomes Cancer 2011 50 812 822 10.1002/gcc.20902 21748820
28. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Wang R, Wang ZX, Yang JS, Pan X, De W, Chen LB, Oncogene 2011 30 2644 2658 10.1038/onc.2010.642 21358675
29. Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Xing L, Todd NW, Yu L, Fang H, Jiang F, Mod Pathol 2010 23 1157 1164 10.1038/modpathol.2010.111 20526284
30. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC, Cancer Cell 2006 9 189 198 10.1016/j.ccr.2006.01.025 16530703
31. The role of microRNA in human lung squamous cell carcinoma. Yang Y, Li X, Yang Q, Wang X, Zhou Y, Jiang T, Ma Q, Wang YJ, Cancer Genet Cytogenet 2010 200 127 133 10.1016/j.cancergencyto.2010.03.014 20620595
32. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Yu L, Todd NW, Xing L, Xie Y, Zhang H, Liu Z, Fang H, Zhang J, Katz RL, Jiang F, Int J Cancer 2010 127 2870 2878 10.1002/ijc.25289 21351266
33. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. Gao W, Shen H, Liu L, Xu J, Xu J, Shu Y, J Cancer Res Clin Oncol 2011 137 557 566 10.1007/s00432-010-0918-4 20508945
34. Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation. Ma Y, Zhang P, Yang J, Liu Z, Yang Z, Qin H, Int J Cancer 2012 130 2077 2087 10.1002/ijc.26232 21671476
35. miRNAs in lung cancer: large roles for small players. Cherni I, Weiss GJ, Future Oncol 2011 7 1045 1055 10.2217/fon.11.74 21919692
36. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT, Carter BS, Krichevsky AM, Breakefield XO, Nat Cell Biol 2008 10 1470 1476 10.1038/ncb1800 19011622
37. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO, Nat Cell Biol 2007 9 654 659 10.1038/ncb1596 17486113
38. Probing microRNAs with microarrays: tissue specificity and functional inference. Babak T, Zhang W, Morris Q, Blencowe BJ, Hughes TR, RNA 2004 10 1813 1819 10.1261/rna.7119904 15496526
39. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. Shen J, Liu Z, Todd NW, Zhang H, Liao J, Yu L, Guarnera MA, Li R, Cai L, Zhan M, Jiang F, BMC Cancer 2011 11 374 10.1186/1471-2407-11-374 21864403
40. Multitarget FISH and LOH analyses at chromosome 3p in non-small cell lung cancer and adjacent bronchial epithelium. Woenckhaus M, Grepmeier U, Wild PJ, Merk J, Pfeifer M, Woenckhaus U, Stoelcker B, Blaszyk H, Hofstaedter F, Dietmaier W, Hartmann A, Am J Clin Pathol 2005 123 752 761 10.1309/ C4BK7GQV8E5XU2TL 15981815
41. Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors. Chandran UR, Dhir R, Ma C, Michalopoulos G, Becich M, Gilbertson J, BMC Cancer 2005 5 45 10.1186/1471-2407-5-45 15892885
42. miR-21 as an Independent Biochemical Recurrence Predictor and Potential Therapeutic Target for Prostate Cancer. Li T, Li RS, Li YH, Zhong S, Chen YY, Zhang CM, Hu MM, Shen ZJ, J Urol 2012 187 1466 1472 10.1016/j.juro.2011.11.082 22341810
43. MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Jamieson NB, Morran DC, Morton JP, Ali A, Dickson EJ, Carter CR, Sansom OJ, Evans TR, McKay CJ, Oien KA, Clin Cancer Res 2012 18 534 545 10.1158/1078-0432.CCR-11-0679 22114136
44. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC, JAMA 2008 299 425 436 10.1001/jama.299.4.425 18230780
45. MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Voortman J, Goto A, Mendiboure J, Sohn JJ, Schetter AJ, Saito M, Dunant A, Pham TC, Petrini I, Lee A, Khan MA, Hainaut P, Pignon JP, Brambilla E, Popper HH, Filipits M, Harris CC, Giaccone G, Cancer Res 2010 70 8288 8298 10.1158/0008-5472.CAN-10-1348 20978195